Kairos Pharma, Ltd. (KAPA) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Kairos Pharma, Ltd. (KAPA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $11.1M, listed on AMEX, employing roughly 1 people, carrying a beta of 1.51 to the broader market. Kairos Pharma, Ltd. Led by John S. Yu, public since 2024-09-16.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for KAPA as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.